Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
Risa Kagan,1,2 Steven R Goldstein,3 James H Pickar,4 Barry S Komm5 1Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 2East Bay Physicians Medical Group, Berkeley, CA, 3Department of Obstetrics and Gynecology, New York University School of Medic...
Saved in:
Main Authors: | Kagan R (Author), Goldstein SR (Author), Pickar JH (Author), Komm BS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
by: Mirkin S, et al.
Published: (2013) -
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
by: Komm BS, et al.
Published: (2012) -
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
by: Rossini M, et al.
Published: (2013) -
The Tissue Selective Estrogen Complex: A Promising New Menopausal Therapy
by: Sebastian Mirkin, et al.
Published: (2012) -
Bazedoxifene for the prevention of postmenopausal osteoporosis
by: Luigi Gennari, et al.
Published: (2008)